• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, August 26, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Discovery of a marker of delayed recovery of concussion in children

Bioengineer by Bioengineer
April 10, 2024
in Science News
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new study aimed at identifying a blood protein marker predictive of delayed recovery of concussion in children showed that alpha-1-antichymotrypsin (alpha-1-ACT) was significantly lower in children with delayed recovery compared to those without delayed recovery. The study is published in the peer-reviewed Journal of Neurotrauma. Click here to read the article now.

About 30-50% of the four million children who experience a concussion each year will experience delayed recovery, where they will continue to experience symptoms more than two weeks after their injury. “We have identified that alpha-1-ACT differentiates between children at risk of delayed recovery from those without delayed recovery from concussion,” state Vicki Anderson, from Murdoch Children’s Research Institute, and coauthors of the study.

“The key to optimum patient outcomes in pediatric concussion is early and accurate diagnosis, effective treatment and safe return to learning, exercise, and sports and leisure,” state the investigators. “In children presenting to acute care services within 48 hours of injury, our results suggest that alpha-1-ACT can contribute to the identification of risk of delayed recovery, enabling clinicians to provide individualized patient management in a timely fashion, and to effectively target scarce education and therapy resources.”

“Congratulations to Dr. Swaney and colleagues for this important work. We desperately need better tools to predict delayed recovery after concussion, and there has been far too little work on this topic in children,” says David L. Brody, MD, PhD, Editor-in-Chief of Journal of Neurotrauma.

About the Journal
Journal of Neurotrauma is an authoritative peer-reviewed journal published 24 times per year in print and online that focuses on the latest advances in the clinical and laboratory investigation of traumatic brain and spinal cord injury. Emphasis is on the basic pathobiology of injury to the nervous system, and the papers and reviews evaluate preclinical and clinical trials targeted at improving the early management and long-term care and recovery of patients with traumatic brain injury. Journal of Neurotrauma is the official journal of the National Neurotrauma Society and the International Neurotrauma Society. Complete tables of content and a sample issue may be viewed on the Journal of Neurotrauma website.

About the Publisher
Mary Ann Liebert, Inc. is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, public health and policy, and technology and engineering. For further information, please visit the Mary Ann Liebert, Inc. website.

Journal of Neurotrauma

Credit: Mary Ann Liebert, Inc.

A new study aimed at identifying a blood protein marker predictive of delayed recovery of concussion in children showed that alpha-1-antichymotrypsin (alpha-1-ACT) was significantly lower in children with delayed recovery compared to those without delayed recovery. The study is published in the peer-reviewed Journal of Neurotrauma. Click here to read the article now.

About 30-50% of the four million children who experience a concussion each year will experience delayed recovery, where they will continue to experience symptoms more than two weeks after their injury. “We have identified that alpha-1-ACT differentiates between children at risk of delayed recovery from those without delayed recovery from concussion,” state Vicki Anderson, from Murdoch Children’s Research Institute, and coauthors of the study.

“The key to optimum patient outcomes in pediatric concussion is early and accurate diagnosis, effective treatment and safe return to learning, exercise, and sports and leisure,” state the investigators. “In children presenting to acute care services within 48 hours of injury, our results suggest that alpha-1-ACT can contribute to the identification of risk of delayed recovery, enabling clinicians to provide individualized patient management in a timely fashion, and to effectively target scarce education and therapy resources.”

“Congratulations to Dr. Swaney and colleagues for this important work. We desperately need better tools to predict delayed recovery after concussion, and there has been far too little work on this topic in children,” says David L. Brody, MD, PhD, Editor-in-Chief of Journal of Neurotrauma.

About the Journal
Journal of Neurotrauma is an authoritative peer-reviewed journal published 24 times per year in print and online that focuses on the latest advances in the clinical and laboratory investigation of traumatic brain and spinal cord injury. Emphasis is on the basic pathobiology of injury to the nervous system, and the papers and reviews evaluate preclinical and clinical trials targeted at improving the early management and long-term care and recovery of patients with traumatic brain injury. Journal of Neurotrauma is the official journal of the National Neurotrauma Society and the International Neurotrauma Society. Complete tables of content and a sample issue may be viewed on the Journal of Neurotrauma website.

About the Publisher
Mary Ann Liebert, Inc. is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, public health and policy, and technology and engineering. For further information, please visit the Mary Ann Liebert, Inc. website.



Journal

Journal of Neurotrauma

DOI

10.1089/neu.2023.0503

Method of Research

Observational study

Subject of Research

People

Article Title

Discovery of Alpha-1-Antichymotrypsin as a Marker of Delayed Recovery from Concussion in Children

Article Publication Date

10-Apr-2024

Share12Tweet7Share2ShareShareShare1

Related Posts

Synergistic Policies Boost Low-Carbon Resilience in Chinese Cities

Synergistic Policies Boost Low-Carbon Resilience in Chinese Cities

August 26, 2025

CHALLENGE Trial Advances Exercise Therapy in Cancer Care

August 26, 2025

Trends and Risks of Cardiac Arrest in China

August 26, 2025

lncRNAs: Key to Colorectal Cancer Diagnosis

August 26, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    147 shares
    Share 59 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Synergistic Policies Boost Low-Carbon Resilience in Chinese Cities

CHALLENGE Trial Advances Exercise Therapy in Cancer Care

Trends and Risks of Cardiac Arrest in China

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.